Abstract:The dopamine (DA) transporter (DAT) is part of a presynaptic multiprotein network involving interactions with scaffold proteins via its C-terminal PDZ domain-binding sequence. Using a mouse model expressing DAT with mutated PDZ-binding sequence (DAT-AAA), we previously demonstrated the importance of this binding sequence for striatal expression of DAT. Here, we show by application of direct stochastic reconstruction microscopy not only that the striatal level of transporter is reduced in DAT-AAA mice but also that the nanoscale distribution of this transporter is altered with a higher propensity of DAT-AAA to localize to irregular nanodomains in dopaminergic terminals. In parallel, we observe mesostriatal DA adaptations and changes in DA-related behaviors distinct from those seen in other genetic DAT mouse models. DA levels in the striatum are reduced to ∼45% of that of WT, accompanied by elevated DA turnover. Nonetheless, fast-scan cyclic voltammetry recordings on striatal slices reveal a larger amplitude and prolonged clearance rate of evoked DA release in DAT-AAA mice compared with WT mice. Autoradiography and radioligand binding show reduced DA D2 receptor levels, whereas immunohistochemistry and autoradiography show unchanged DA D1 receptor levels. In behavioral experiments, we observe enhanced self-administration of liquid food under both a fixed ratio of one and progressive ratio schedule of reinforcement but a reduction compared with WT when using cocaine as reinforcer. In summary, our data demonstrate how disruption of PDZ domain interactions causes changes in DAT expression and its nanoscopic distribution that in turn alter DA clearance dynamics and related behaviors.

Regulation of Dopamine Transporter Activity by Carboxypeptidase E

Protein kinase Cβ is a modulator of the dopamine D2 autoreceptor-activated trafficking of the dopamine transporter

Regulation of the dopamine transporter: aspects relevant to psychostimulant drugs of abuse

Carboxypeptidase E Regulates Activity-Dependent TrkB Neuronal Surface Insertion and Hippocampal Memory.

Dopamine transporter endocytic trafficking: Neuronal mechanisms and potential impact on DA‐dependent behaviors

Protein Kinase Cbeta is a Critical Regulator of Dopamine Transporter Trafficking and Regulates the Behavioral Response to Amphetamine in Mice.

Expression and regulation of the human dopamine transporter in a neuronal cell line (vol 59, pg 66, 1998)

Growth Associated Protein‐43 Modulates Dopamine Transporter Function

Dopamine Transporter Trafficking: Rapid Response on Demand.

Vps35 Regulates Cell Surface Recycling and Signaling of Dopamine Receptor D1

Calmodulin Kinase II Interacts with the Dopamine Transporter C Terminus to Regulate Amphetamine-Induced Reverse Transport

Carboxypeptidase E （Nf-Α1）： a New Trophic Factor in Neuro- Protection

Intracellular Ca2+ Regulates Amphetamine-Induced Dopamine Efflux and Currents Mediated by the Human Dopamine Transporter.

Substrate-induced Conformational Dynamics of the Dopamine Transporter

Protein Kinase D1-Dependent Phosphorylation of Dopamine D1 Receptor Regulates Cocaine-Induced Behavioral Responses

Disruption of the PDZ domain-binding motif of the dopamine transporter uniquely alters nanoscale distribution, dopamine homeostasis, and reward motivation

Development of Peptidic Dopamine Transporter Inhibitors Via Aromatic Modification-Mediated Conformational Restriction.

Peptide Derived from Insulin with Regulatory Activity of Dopamine Transporter

Syntaxin 1a Interaction with the Dopamine Transporter Promotes Amphetamine-Induced Dopamine Efflux

Identification of a Vav2-dependent mechanism for GDNF/Ret control of mesolimbic DAT trafficking

Dissecting carboxypeptidase E: properties, functions and pathophysiological roles in disease